No place for Dalits and backwards in the heart of Congress: PM Modi

Agencies
May 10, 2018

Bengaluru, May 10: There is no place for Dalits and backward classes in the heart of the Congress, Prime Minister Narendra Modi said on Thursday, asserting his government is trying to realise B R Ambedkar's dream of a powerful and prosperous India.

Launching a blistering attack on the Congress over the way it has treated Dalits, Modi said the party showed no respect for Ambedkar.

The Congress, he alleged, used "all its power" to defeat Ambedkar when he contested Lok Sabha election in 1952 and Bandara Lok Sabha by-election in 1953.

"That is the reason why Baba Saheb had to face defeat and insult. Let Congress show at least one thing it did to honour Baba Saheb," he said.

Addressing BJP's SC/ST/OBC and Slum Morcha workers through his Namo App, Modi said, "There is no place for Dalits and backward classes in the heart of the Congress."

"This has been happening for decades. Till the time the Congress party was in power, Baba Saheb was not given Bharat Ratna," he said.

Maintaining that Ambedkar dreamt of an India which takes everybody forward together, he said the BJP is trying to fulfil his dream by implementing various schemes.

The government, he said, is making efforts to ensure there is social justice and equality.

Modi said 'Stand Up' and 'Mudra' Yojanas are playing a major role in the financial empowerment of scheduled castes, scheduled tribes, OBCs and women.

Noting that the BJP has the most number of MPs belonging these categories, Modi said, it was for the first time after Independence that the Atal Bihari Vajpayee government created a separate ministry for scheduled tribes.

Also, it was under Vajpayee that the government created a separate national commission for scheduled tribes, he said.

Modi said the BJP has its governments in Madhya Pradesh, Maharashtra, Gujarat, Rajasthan, Jharkhand and Chhattisgarh which have sizeable tribal population.

It is also in power in northeastern states like Assam, Arunachal Pradesh, Manipur and Tripura, and is part of coalition dispensations in Nagaland and Meghalaya."This shows that tribal people are fully supporting BJP," he said.

He said the party's manifesto for Karnataka elections has details of the programmes its government will undertake for the empowerment of the scheduled tribes.

In Chitradurga, Mysuru, Uttar Kannada and Bagalkot, the government will set up four 'sindhoora laxman training centres' for vocational training, he said.

Modi said the Congress never thought of giving constitutional status to OBC Commission.

"What problem they have I am yet to understand. Every time they create obstacles despite the community's demand for it," he said.

The Congress, he said, did not allow Parliament to function to block the government's move to accord constitutional status to OBC Commission.

Modi said his government made provisions of SC/ST (Prevention of Atrocities) Act more stringent and increased the number of offences listed under it from 22 to 47.

"The government did this because I know what problems the poor face, what pain Dalits and tribals suffer, and what kind of language is used against them.

"He asked BJP workers to visit the homes of people belonging to scheduled castes, scheduled tribes and backward classes to reassure them that BJP will work for their welfare.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 27,2020

New Delhi, Feb 27: An Indian Air Force aircraft on Thursday evacuated 76 Indians and 36 foreign nationals from the coronavirus-hit Chinese city of Wuhan.

The C-17 Globemaster III transport aircraft was sent to Wuhan on Wednesday and it carried 15 tonnes of medical supplies for coronavirus-affected people in China.

On its return, the aircraft brought back 112 people, including 23 citizens from Bangladesh, six from China, two each from Myanmar and the Maldives and one each from South Africa, the US and Madagascar.

Earlier, India had evacuated around 650 Indians from Wuhan in two Air India flights.

“In all 723 Indian nationals and 43 foreign nationals have been evacuated from Wuhan, China, in these three flights,” the Ministry of External Affairs (MEA) said.

On the medical supplies delivered by India to China, the MEA said they would help augment the country’s efforts to control the coronavirus outbreak which had been declared as a public health emergency by the World Health Organisation.

“The assistance is also a mark of friendship and solidarity from the people of India towards the people of China as the two countries also celebrate 70th anniversary of establishment of diplomatic relations this year,” it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 4,2020

The government suspended all the India-bound air travel from China and has declared all visas 'invalid', on Monday, due to the rapid escalation of cases of novel coronavirus outbreak which originated in Wuhan.

"Embassy and our Consulates have been receiving several queries from Chinese citizens as well as other foreign nationals, who are based out of China or visited China in the last 2 weeks, as to whether they can use their valid single/multiple entry visas to travel to India," tweeted the Embassy of India in Beijing, China.

"It is clarified that existing visas are no longer valid. Intending visitors to India should contact the Indian Embassy in Beijing ([email protected]) or the Consulates in Shanghai ([email protected]) and Guangzhou ([email protected]) to apply afresh for an Indian visa," it said.

Further, regarding the validity of visas, the embassy said, "Indian Visa Application Centres (http://blsindia-china.com) in these cities may also be contacted in this regard. Visa Section of the Embassy/Consulates of India in China can be contacted to ascertain the validity of visa before undertaking any visit to India."

"All those who are already in India (with regular or e-visa) and had traveled from China after January 15 are requested to contact the hotline number of Ministry of Health and Family Welfare of Government of India (+91-11-23978046 and email: [email protected])," the embassy said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.